Avanos Medical (AVNS) Accumulated Expenses (2013 - 2026)

Avanos Medical's Accumulated Expenses history runs 14 years deep, the most recent figure standing at $57.6 million for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 19.33% year-over-year to $57.6 million; the TTM figure through Mar 2026 stood at $57.6 million (down 19.33% YoY), while the FY2025 annual figure was $91.3 million, changed 0.0% from the prior year.
• Accumulated Expenses came in at $57.6 million for Q1 2026 at Avanos Medical, down from $91.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $97.8 million in Q4 2022 to a low of $57.6 million in Q1 2026.
• A 5-year average of $79.7 million and a median of $79.5 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses surged 43.61% in 2022 and fell 19.33% in 2026, its largest moves.
• Avanos Medical's Accumulated Expenses stood at $97.8 million in 2022, then dropped by 4.7% to $93.2 million in 2023, then dropped by 2.04% to $91.3 million in 2024, then changed by 0.0% to $91.3 million in 2025, then sank by 36.91% to $57.6 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $57.6 million, $91.3 million, and $74.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison